|
||||
|
Published by : PROFESSIONAL MEDICAL PUBLICATIONS |
||||
|
ISSN 1681-715X |
||||
|
||||
|
- |
||||
|
ORIGINAL ARTICLE |
||||
|
- |
||||
|
Volume 26 |
July - September 2010 |
Number 3 |
||
|
|
||||
|
|
||||
|
||||
|
Published by : PROFESSIONAL MEDICAL PUBLICATIONS |
||||
|
ISSN 1681-715X |
||||
|
||||
|
- |
||||
|
ORIGINAL ARTICLE |
||||
|
- |
||||
|
Volume 26 |
July - September 2010 |
Number 3 |
||
|
|
||||
|
|
||||
The relationship of visfatin with measures of
obesity in patients of diabetic nephropathyNosheen Mahmood1, Qamar Jamal2, Abdul Manan Junejo3
ABSTRACT
Objective: Visfatin is proposed as an adipocytokine secreted from visceral fat and its blood level correlate with obesity, diabetes mellitus and inflammation. Aim of this study was to examine association of serum visfatin with measures of obesity in a group of patients with diabetic nephropathy and normal controls.
Methodology: This was a cross sectional study analyzing 60 subjects including 30 patients of diabetic nephropathy and 30 controls. Anthropometric measurements were done using standard methods and visfatin was measured through EIA Kit.
Results: Serum visfatin in obese subjects among both groups was not different from non obese subjects (7.9 ±6.1 vs. 6.4 ± 3.2 p=0.238). We found a positive correlation of visfatin with BMI (r=0.313, p<0.05) but no correlation with waist circumference (r=0.148 p=0.695) and waist to hip ratio (0.198, p=0.136). Serum visfatin in subjects of diabetic nephropathy and non diabetics was (9.2 ±5.4 vs. 5.2 ±3.4 p<0.05.
Conclusion: Serum visfatin does not correlate with markers of visceral obesity including waist circumference and waist to hip ratio. However, a positive correlation is observed with BMI. Future studies involving larger sample size and quantifying visceral tissue expression of visfatin may explain its potential role in visceral obesity.
KEY WORDS:
Visfatin, Obesity, Body Mass Index, Visceral Obesity.Pak J Med Sci July - September 2010 Vol. 26 No. 3 556-561
How to cite this article:
Mahmood N, Jamal Q, Junejo AM. The relationship of visfatin with measures of obesity in patients of diabetic nephropathy. Pak J Med Sci 2010;26(3):556-561
1. Dr. Nosheen Mahmood, MBBS,
Lecturer, Department of Pathology.
2. Prof. Qamar Jamal, MBB, M Phil, PhD,
Head of Pathology Department.
3. Dr. Abdul Manan Junejo, MBBS, FCPS (Nephrology),
Assistant Professor, Department of Nephrology,
Jinnah Post Graduate Medical Centre,
Karachi, Pakistan.
1,2: Ziauddin University,
Karachi - Pakistan.
Correspondence:
Dr. Nosheen Mahmood, MBBS,
F-1, Shamim Appartments,
Block- 10, F.B Area,
Karachi, Pakistan.
E-mail: saifayan12@yahoo.com
* Received for Publication: December 18, 2009
* Accepted: March 16, 2010
HOME | SEARCH | CURRENT ISSUE | PAST ISSUES
Professional
Medical Publications
Room No. 522, 5th Floor, Panorama Centre
Building No. 2, P.O. Box 8766, Saddar, Karachi - Pakistan.
Phones : 5688791, 5689285 Fax : 5689860
pjms@pjms.com.pk
